Literature DB >> 32935310

Oral Anticoagulant Use in a Racial and Ethnically Diverse Population with Atrial Fibrillation.

Ankur Srivastava1, Eric Sun2, Aliasakar Hasani2, John D Fisher2, Kevin J Ferrick2, Andrew K Krumerman3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32935310      PMCID： PMC8390707          DOI： 10.1007/s11606-020-06184-4

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   6.473


× No keyword cloud information.
  6 in total

1.  2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Hugh Calkins; Lin Y Chen; Joaquin E Cigarroa; Joseph C Cleveland; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Karen L Furie; Paul A Heidenreich; Katherine T Murray; Julie B Shea; Cynthia M Tracy; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2019-01-28       Impact factor: 24.094

2.  Race- and sex-related differences in care for patients newly diagnosed with atrial fibrillation.

Authors:  Prashant D Bhave; Xin Lu; Saket Girotra; Hooman Kamel; Mary S Vaughan Sarrazin
Journal:  Heart Rhythm       Date:  2015-03-23       Impact factor: 6.343

3.  Evolution of Medicare Formulary Coverage Changes for Antithrombotic Therapies After Guideline Updates.

Authors:  Elias J Dayoub; Joseph S Ross; Nilay D Shah; Sanket S Dhruva
Journal:  Circulation       Date:  2019-09-30       Impact factor: 29.690

4.  Disparities and Temporal Trends in the Use of Anticoagulation in Patients With Ischemic Stroke and Atrial Fibrillation.

Authors:  Nicole B Sur; Kefeng Wang; Marco R Di Tullio; Carolina M Gutierrez; Chuanhui Dong; Sebastian Koch; Hannah Gardener; Enid J García-Rivera; Juan Carlos Zevallos; W Scott Burgin; David Z Rose; Jeffrey J Goldberger; Jose G Romano; Ralph L Sacco; Tatjana Rundek
Journal:  Stroke       Date:  2019-05-14       Impact factor: 7.914

5.  Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation: Findings From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II.

Authors:  Utibe R Essien; DaJuanicia N Holmes; Larry R Jackson; Gregg C Fonarow; Kenneth W Mahaffey; James A Reiffel; Benjamin A Steinberg; Larry A Allen; Paul S Chan; James V Freeman; Rosalia G Blanco; Karen S Pieper; Jonathan P Piccini; Eric D Peterson; Daniel E Singer
Journal:  JAMA Cardiol       Date:  2018-12-01       Impact factor: 14.676

6.  Referral Patterns for Primary Prophylaxis Implantable Cardioverter Defibrillator Therapy for an Urban US Population.

Authors:  Eric D Manheimer; Christian Gonzalez; Jordan Turk; Andrew K Krumerman; Soo G Kim; Jay N Gross; Eugen C Palma; Michael J Grushko; John D Fisher; Kevin J Ferrick
Journal:  Am J Cardiol       Date:  2015-07-28       Impact factor: 2.778
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.